These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment. Mahboubi-Rabbani M; Zarghi A Anticancer Agents Med Chem; 2021 Oct; 21(16):2163-2180. PubMed ID: 33511940 [TBL] [Abstract][Full Text] [Related]
4. The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II. Knudsen JF; Carlsson U; Hammarström P; Sokol GH; Cantilena LR Inflammation; 2004 Oct; 28(5):285-90. PubMed ID: 16134002 [TBL] [Abstract][Full Text] [Related]
5. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236 [TBL] [Abstract][Full Text] [Related]
6. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Supuran CT; Casini A; Mastrolorenzo A; Scozzafava A Mini Rev Med Chem; 2004 Aug; 4(6):625-32. PubMed ID: 15279596 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety. Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis. Akgul O; Di Cesare Mannelli L; Vullo D; Angeli A; Ghelardini C; Bartolucci G; Alfawaz Altamimi AS; Scozzafava A; Supuran CT; Carta F J Med Chem; 2018 Jun; 61(11):4961-4977. PubMed ID: 29746127 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs. Dogné JM; Thiry A; Supuran CT Curr Pharm Des; 2008; 14(7):679-84. PubMed ID: 18336314 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy. Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors. Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084 [TBL] [Abstract][Full Text] [Related]
13. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal. Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076 [TBL] [Abstract][Full Text] [Related]
14. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies. Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095 [TBL] [Abstract][Full Text] [Related]
15. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors. Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419 [TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds. Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309 [TBL] [Abstract][Full Text] [Related]
17. The anti-proliferative potency of celecoxib is not a class effect of coxibs. Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544 [TBL] [Abstract][Full Text] [Related]
18. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action. Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX. Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081 [TBL] [Abstract][Full Text] [Related]
20. Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II. Katagiri M; Ogasawara T; Hoshi K; Chikazu D; Kimoto A; Noguchi M; Sasamata M; Harada S; Akama H; Tazaki H; Chung UI; Takato T; Nakamura K; Kawaguchi H J Bone Miner Res; 2006 Feb; 21(2):219-27. PubMed ID: 16418777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]